Pi3k inhibitors for treating cough

A technology for medicinal salts and compounds, which can be used in medical preparations containing active ingredients, drug combinations, organic chemistry, etc., and can solve the problems that no substantial progress has been obtained.

Inactive Publication Date: 2014-10-08
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
View PDF13 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although some of the underlying mechanisms of cough are now better understood, no substantial progress has been made in the treatment of this condition, and some authors have emphasized the need for safe and effective antitussive treatments [Dicpinigaitis, 2011; McGarvey, 2010; Chung, 2008 ]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pi3k inhibitors for treating cough
  • Pi3k inhibitors for treating cough
  • Pi3k inhibitors for treating cough

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] In one embodiment, the present invention provides a compound of formula (I)

[0037]

[0038] in

[0039] X is -CH- and Y is 4-pyridazinyl; or

[0040] X is -N- and Y is 4-morpholinyl;

[0041] or its pharmaceutically acceptable salts for the treatment of cough.

[0042] In another embodiment, the present invention provides compound 2,4-difluoro-N-{2-(methoxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3 -pyridyl}benzenesulfonamide:

[0043]

[0044] or its pharmaceutically acceptable salts for the treatment of cough.

[0045] In another embodiment, the present invention provides compound 2,4-difluoro-N-{2-(methoxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3 -pyridyl}benzenesulfonamide:

[0046]

[0047] Used to treat coughs.

[0048] In another embodiment, the present invention provides compound 2,4-difluoro-N-{2-(methoxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3 -pyridyl}benzenesulfonamide:

[0049]

[0050] or a pharmaceutically acceptable salt thereof, for the tr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to compounds or pharmaceutically acceptable salts thereof for use in the treatment of cough, in particular idiopathic chronic cough, cough variant asthma, cough associated with thoracic tumour or lung cancer, viral and post-viral cough, upper airways cough syndrome (UACS) or post nasal drip cough, and cough associated with disorders such as gastro oesophageal reflux disease (both acid and non acid reflux), chronic bronchitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease (the as idiopathic pulmonary fibrosis (IPF)), congestive heart disease, sarcoidosis and infection (the as whooping cough).

Description

field of invention [0001] The present invention relates to compounds and pharmaceutically acceptable salts thereof, which are members of the phosphoinositide 3'OH kinase family (hereinafter referred to as PI3K, including PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ) and the mammalian target of rapamycin (hereinafter referred to as mTOR , an inhibitor of the activity or function of PI3K downstream signaling target), for the treatment of cough, especially idiopathic chronic cough, cough variant asthma, cough associated with thoracic tumors or lung cancer, viral and postviral cough (post-viral cough), upper airway cough syndrome (UACS) or postnasal drip cough, and cough associated with conditions such as gastroesophageal reflux disease (acid reflux and non-acid reflux), chronic Bronchitis, chronic obstructive pulmonary disease (COPD), interstitial lung disease (such as idiopathic pulmonary fibrosis (IPF)), congestive heart disease, sarcoidosis, and infections (such as whooping cough). Backgro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/501A61K31/5377A61P11/14
CPCA61K31/501A61K31/5377C07D401/14A61P11/14A61P43/00
Inventor E·默洛皮施
Owner GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap